Back
Consulting

Portfolio buy and build

Top 10 pharma corporate development strategy validated by external market and stakeholder insight

Discovery and analysis

A thorough market assessment of current and evolving landscape and competitors including scientific and clinical innovations, high potential molecular targets and treatment classes of the future, anticipated evolution in treatment and management strategies, outcomes, and early commercial attractiveness. 


OUTPUT: initial findings report outlining areas of anticipated evolution and attractiveness relative to client pipeline.

Insight and validation

External stakeholder engagement to elicit insight relating to market assessment, predictions and competitor strategies. Validate initial findings report and address subsequent client questions. Identification and recruitment of the relevant stakeholders including clinical, payor, regulatory, advocacy, etc.


OUTPUT: validated findings report providing recommended areas of interest and potential investment, and specific companies/targets of interest.

Strategy development

Engagement of internal team on methodology for initial assessment, interim findings and recommendations.

Support for subsequent broad TA strategy development and preparation of collateral to support internal and external engagement aligned to strategy.

OUTPUT: internal alignment on strategy and strategy implementation